Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Clinical Trial of Noradrenergic Add-on Therapy With Extended-Release Guanfacine in Alzheimer's Disease

NCT03116126 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03116126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03116126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Clinical Trial of Noradrenergic Add-on Therapy With Extended-Release Guanfacine in Alzheimer's Disease
Lead sponsor
Imperial College London
Phase
Phase 3
Overall status
Unknown status
Start date
January 4, 2019
Completion date
August 5, 2024
Enrollment
148 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease